AbbVie’s Juvmo Wins FDA Approval for Parkinson’s Disease
AbbVie has received U.S. Food and Drug Administration (FDA) approval for JUVMO (tavapadon), a once-daily oral treatment for adults with Parkinson’s disease. The approval makes JUVMO the…
Read More...
Read More...
